[
    [
        {
            "time": "",
            "original_text": "“吃药”行情不再，CRO如惊弓之鸟，同仁堂跻身市值前十「制药行业周榜」",
            "features": {
                "keywords": [
                    "吃药",
                    "CRO",
                    "惊弓之鸟",
                    "同仁堂",
                    "制药行业"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "“吃药”行情不再，CRO如惊弓之鸟，同仁堂跻身市值前十「制药行业周榜」",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "FMR LLC增持凯莱英(06821)6.96万股，每股作价约361.67港元",
            "features": {
                "keywords": [
                    "FMR LLC",
                    "增持",
                    "凯莱英",
                    "H股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "FMR LLC增持凯莱英(06821)6.96万股，每股作价约361.67港元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【行情】CRO板块拉升反弹，凯莱英、康龙化成、博腾股份、药石科技、药明康德、昭衍新药等集体冲高",
            "features": {
                "keywords": [
                    "CRO",
                    "板块",
                    "拉升",
                    "反弹",
                    "凯莱英",
                    "康龙化成",
                    "博腾股份",
                    "药石科技",
                    "药明康德",
                    "昭衍新药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【行情】CRO板块拉升反弹，凯莱英、康龙化成、博腾股份、药石科技、药明康德、昭衍新药等集体冲高",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "港股盘前必读：英国基准利率上调15个基点，美股全线大跌",
            "features": {
                "keywords": [
                    "英国",
                    "基准利率",
                    "上调",
                    "美股",
                    "大跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股盘前必读：英国基准利率上调15个基点，美股全线大跌",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "凯莱英获FMR LLC增持6.96万股H股",
            "features": {
                "keywords": [
                    "凯莱英",
                    "FMR LLC",
                    "增持",
                    "H股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "凯莱英获FMR LLC增持6.96万股H股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]